Abstract
Objective: To review the efficacy and safety of nusinersen (Spinraza) in the treatment of spinal muscular atrophy (SMA). Data Sources: An English-lang......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
